Neoral is an immunosuppressive medication classified as a calcineurin inhibitor used to prevent organ transplant rejection. It works by inhibiting the enzyme calcineurin, which normally activates t-cell transcription factors. This inhibition reduces the production of interleukins, particularly interleukin-2, that are essential for t-cell proliferation. By limiting t-cell activation, Neoral diminishes the immune response that would otherwise attack the transplanted organ. The drug is formulated as a modified-release oral capsule that ensures steady blood levels over time. It binds selectively to cyclophilin, a cytoplasmic protein, forming a complex that blocks calcineurin activity. The resulting decrease in immune activation allows the new organ to function without excessive rejection risk. Neoral is primarily prescribed to patients who have received kidney, liver, or heart transplants to maintain graft survival.

Neoral is an immunosuppressant medication used to prevent organ rejection after transplantation. It acts by inhibiting t cell activation through calcineurin blockade. Cyclosporine in Neoral binds to cyclophilin and forms a complex that suppresses calcineurin phosphatase activity. This reduces the production of interleukin 2 and other cytokines that drive immune responses. The pharmacological profile of Neoral includes high oral bioavailability and consistent absorption compared to earlier cyclosporine formulations. Its long half-life allows once daily dosing in some patients but requires monitoring of blood levels to maintain therapeutic effect. By modulating immune cell activity Neoral helps preserve transplanted organs and treat certain autoimmune skin conditions. The medication's therapeutic role relies on selective suppression of immune signaling pathways to achieve clinical benefit.

Common side effects of Neoral may include high blood pressure and kidney dysfunction. Patients may also experience tremors, gum swelling, or excessive hair growth. Some individuals report headaches, nausea, or changes in taste. These effects often depend on dosage and individual health factors. Regular monitoring by healthcare providers helps identify any emerging issues early. Adjustments to treatment can be made if side effects become problematic.

Neoral can raise blood pressure in some patients. It may alter kidney function and raise serum creatinine levels. Changes in gum tissue such as swelling or overgrowth have been observed. Tremors or shaking of the hands sometimes appear. Increased uric acid levels may lead to gout-like symptoms. Skin sensitivity to sunlight can be heightened in certain individuals.